chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient was not vaccinated at hospital.  Caregiver reports that patient was vaccinated with second dose on Monday 2/15/21.  Tuesday patient experienced n/v/d.  Went to an ED on Wednesday and was cleared and sent home.  Thursday reported shortness of breath to her caregiver and then collapsed.  Patient was brought to as PEA arrest and ultimately died.
After receiving COVID 19 vaccine the patient instructed to sit for 15 minutes. During his 15 minute window the patient stated he got anxious and went to the bathroom to splash water on his face. Patient stated he felt tingling and passed out. Patient fell forward hitting left side of face on the toilet.
pt recv vax 6MAY99 & 24hr p/vax noted tender knot in vicinity of inj;examined 10MAY99 mass 5x4cm;tender soft tissue mass;felt to be localized;
"COVID arm" ... red itchy rash around the injection site.  It started out as a bright red patch about 4-5" in diameter.  This has faded into a red ring of approximately the same diameter.  It has been intermittently itchy, but not painful/sore.
Initial information received on 21-Jan-2019 regarding an unsolicited valid non-serious case received from a consumer. This case involves a over 65 years old female patient who experienced weight loss of 10 pounds, dizziness, weakness, hair loss and diarrhea, while she received vaccine FLUZONE HIGH DOSE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 28-Sep-2018, the patient received a 0.5 ml dose  of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (lot: UJ004AB, expiry date: 30-MAR-2019) via intramuscular route in the left arm. On an unknown date, the patient developed a non-serious weight loss of 10 pounds, dizziness, weakness, hair loss and diarrhea (Unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. (Other relevant tests included No lab data.) Final diagnosis was diarrhea, weakness, dizziness, hair loss and weight loss of 10 pounds. The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) for Diarrhoea. On an unknown date, the patient outcome was not reported. List of document held by sender: none.
No energy; Little nauseated; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (No energy), NAUSEA (Little nauseated) and PAIN IN EXTREMITY (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (No energy), NAUSEA (Little nauseated) and PAIN IN EXTREMITY (Sore arm). At the time of the report, ASTHENIA (No energy), NAUSEA (Little nauseated) and PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Patient suddenly became diaphoretic eyes rolled back in head, almost passed out . Onsite EMS was called vitals HR 42 BP 95/59 98% O2  refused glucose check. Patient felt better and reluctantly was transported to local hospital. No reaction to 1st vaccine on 3/12/21
Post vax, the pt developed aseptic meningitis, fever, headaches, and a stiff neck.
has had 3  doses of covid vaccine and on 6/29/22 was admitted to hospital with  covid 19 virus infection and Acute respiratory failure with hypoxia, weakness and fever from covid-19 resulting in fall and inability to get off of the floor. Was started on Remdesivir and decadron on 6/30/22
Noted swelling to right tricep where Varicella was administered. Also erythema, tenderness to touch and warmness to area.
patient was admitted to hospital with covid on 3/15/2021, wife called us on 3/18/21 to inform us husband was hospitalized.
Hives all over body and face, Atarax 7ml Q 6 x 24 - 48 hours.
3/17pm face/neck/chest flushed, worsened over 3 days. 3/20 to UrgentCare w/full body redness/itching /painful puffy lips/sore throat. Started on 5d of prednisone 20mg; w/o relief by D#3. PMD increased prednisone to 60mg/d + 12 d taper + Pepcid + Zyrtec. 4/5 (day after taper ended) red face/neck/chest intensified, never fully resolved. By 11pm swollen glands--throat/neck + sore; body aches; fever; migraine (L-side, not usual central & no relief w/Maxalt Rx). Small relief w/Benadryl + Tylenol. 4/7 fever/swollen glands/neck/throat resolved, but red face/neck/chest + migraine remain and no relief w/15mg oxycodone + Maxalt so went to ER. Given IV fluid bolus + metoCLOPramide +diphenhydrAMINE + dexAMETHasone w/90% relief. Redness persists and migraine has returned with limited response to her current meds.
28NOV91 pain, swelling, inc warmth & lump on LA @ site of shot; c/o pain, swelling & tenderness in joints; c/o wheezing; Seen by MD x 2; hospitalized x 2 days; dx w/Bell's palsey; c/o hearing loss 1 ear; tremors, nervous, depressed & teary;
A week after I got the vaccine, I started having random allergic reactions. My lips or eyes would swell almost shut, and I had hives everywhere. This was 8 months ago and since then I have been having allergic reactions every 3 days. I?ve been put on so much medication but absolutely nothing helps. I have never ever had this problem before no allergies nothing until a week after my vaccine. I?ve been in touch with a ton of people online who have this exact same issue as I do, photo evidence and all. I can provide about 60 photos of what the past 8 months of my life looks like. I am sad and scared that this will be permanent. I can barely leave my house.
Hives and burning /itching from the inside .  Light bruising on areas NOT around the injection site.  Calf, wrist, opposie arm
pt developed muscle fatigue (felt like he worked out), recurring paresthesias persisting for at least 2 months.   In addition, had difficulty focusing his vision with a dull pain in his left eye.  He also had intermittent chills and funny sensation of his tongue. Symptoms worsened following 2nd and 3rd vaccine in the series.
Very swollen arm at injection site. Flu like symptons. Headaches, Severe chills. Fever. Sore muscles mostly in legs and neck.Tiredness. Loss of apetite. Had to take today off work-sick day- due to not feeling well, 2 days after shot. I had very similar symptons 10 weeks ago when i got the first shot for shingles. Took Aleve and that has helped with the muscle pain and swollen arm.
Reports "cold" with intermittent congestion, sinus drains age, head aching beginning 7/13;  on 7/25 "stayed in bed all day "and frequent diarrhea, same symptoms recurred 8/1 & 8/2;  8/3 sore throat, cold sore, & much chest mucus;  also "fever" (T=99) chills, "pins/needles" & tingling all over on day of injection.
One week after the first shot I started having abnormal vaginal spotting. I have not had a period since before getting the first dose.    I noticed extreme thirst hours after getting both doses that lasted about 24 hours.
Mild symtoms. About 25 minutes after receiving injection felt slight inflammation on both cheeks near the nose, also notice splotchiness on cheeks. In addition felt slight itch on inside of both elbows which presented a couple hive-like bumps not previously there.  These symptoms continued for about 15 minutes and then began disappearing by the time I reached home. After 45 minutes all adverse reactions were no longer present. No adverse reactions occurred following this except for a sore left arm at injection site.  Arm soreness was abating by 9pm on same date and pretty much gone by next morning.  No additional medication was taken for for any of the reactions. A cool compress was used on the left arm.
Widespread enlarged lymph nodes; Fatigue; Loss of appetite; This is a spontaneous report from a contactable healthcare professional (patient). A 34-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on left arm on 02Jan2021 at a single dose for COVID-19 immunization. There were no medical history and concomitant medications. The patient is not pregnant at the time of vaccination. The patient had no known allergies. The patient had no COVID prior vaccination. No other vaccine administered in four weeks and no other medications in two weeks. On 09Jan2021, the patient experienced widespread enlarged lymph nodes, fatigue and loss of appetite. The events resulted in doctor office/clinic and emergency room/department or urgent care visit. The treatment of the events included "Antibiotics to date". The patient was COVID-19 tested post vaccination on 07Jan2021, the COVID-19 test type post vaccination was Nasal Swab with negative result. The outcome of the events was not recovered.  Information about Lot/Batch number has been requested.
Changing in blood counting; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD COUNT ABNORMAL (Changing in blood counting) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     Concurrent medical conditions included Multiple myeloma in remission (In remission more than 7 months.). Concomitant products included POMALIDOMIDE (POMALYST), DEXAMETHASONE (DEXAMETHAZONE) and DARATUMUMAB (DARZALEX) for Multiple myeloma.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced BLOOD COUNT ABNORMAL (Changing in blood counting). At the time of the report, BLOOD COUNT ABNORMAL (Changing in blood counting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Blood test: unknown (abnormal) Changing in blood counting.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient was reported to have multiple myeloma and was in remission for more than 7 months at the time of the first vaccine dosing. She received the second dose of the Moderna vaccine on 18-FEB-2021.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No treatment medications were reported.   This case was linked to MOD-2021-101078 (Patient Link).
I was falling asleep when I was woken up by the sense that my lower lip felt like it was moving up and down, and my chin was throbbing. I could hear my heart beat (I don't usually hear it)  and it was very fast. I stayed where I was and focused on calming myself- taking slow and steady breaths to slow my heart down. It seemed to work a bit, but then my heart picked up again so I had to do it again. I think this whole episode lasted about half an hour- but I did not check the clock so I am not sure. I thought it was just a normal immune response until I mentioned it to a friend.
This case was reported by a healthcare professional and described the occurrence of fever in a 43-year-old male subject who was vaccinated with BOOSTRIX, (GlaxoSmithKline). The subject's medical history included umbilical hernia and wart. The subject had no allergy and no previous reaction to vaccination. On 10 June 2014 the subject received unspecified dose of BOOSTRIX (0.5 ml, intramuscular, right arm). On 11 June 2014, 1 day after vaccination with BOOSTRIX, the subject experienced fever and swelling at injection site. The injection site also became red, itchy and painful. He was seen at the office on 13 June 2014. The subject was advised to use ibuprofen, TYLENOL and KEFLEX. Fever resolved on 14 June 2014. At the time of reporting, the injection site reaction was improving. The nurse was not sure if it was a local reaction or a bacterial infection of the skin. Follow-up information received on 14 July 2014: On 10 June 2014 (not on 11 June 2014 as previously reported), less than one day after vaccination with BOOSTRIX, the subject experienced fever and swelling at injection site. The injection site also became red, itchy and painful. On 14 June 2014, the events were resolved.
Faint; weakness; confused; Numbness in left arm, left side of face and tongue; nausea; fatigue; Headache; A spontaneous report was received from a Nurse, concerning herself, a 45-years-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced numbness in left arm, left side of face and tongue, faint, weakness, confused, nausea, headache and fatigue.  Patient current condition included unknown allergies. No concomitant product use was mentioned by the reporter.  On 10 Mar 2021, prior to the onset of event, the patient received her first of two planned doses of mRNA-1273 (Lot number: 024M20A) via intramuscular route for prophylaxis of COVID-19 infection.  On 10-mar-2021, patient received mRNA-1273 vaccine and patient waited for about 30 minutes after the injection. However, about 45 minutes later on the drive home she developed numbness in left arm. about two to three minutes later the left side of face felt numb, and finally her tongue became numb too. she took benadryl and symptoms improved. Then a few hours later, she felt faint, nausea and weak. over the next few days she also felt fatigue, confused, headache.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of events numbness in left arm was reported as recovered, whereas outcome of events faint, weakness, confused, nausea, headache and fatigue was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
immunnocompromised; This is a spontaneous report from a contactable consumer (patient).This patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), Dose 1 on an unspecified date and Dose 2 on Mar2021; both via an unspecified route of administration at single dose for COVID-19 immunization. Medical history and concomitant medication were unknown. The patient was interested in the clinical trials for the booster. The patient was immunnocompromised. Outcome of the event was unknown.   No follow-up attempts are possible, information about lot/batch number cannot be obtained.
PATIENT WAS GIVEN .5ML OF VACCINE (IN TWO .25 SHOTS) AND SHOULD HAVE RECEIVED .25
Injection site soreness for several days after the injection Headache several hours though out the evening the day after the injection Muscle pain though out the afternoon and evening the day after the injection Chills for several hours though out the evening the day after the injection Joint pain though out the afternoon and evening the day after the injection Low fever for several hours though out the evening the day after the injection Injection site swelling second and third day after the injection Generally feeling unwell though out the afternoon and evening the day after the injection
Started w/chills around 2000hrs then fever and body aches w/disturbing dreams and a large area (3X10 inches) of redness at the injection site radiating upwards towards the shoulder and continuing to this evening with the redness.  Still achy but no fever or chills.
Weakness in muscles and legs; Fell twice after losing balance; a fall; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Weakness in muscles and legs), BALANCE DISORDER (Fell twice after losing balance), FALL (a fall) and FATIGUE (Fatigue) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. CA5A21A and 016821A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-May-2021, the patient experienced MUSCULAR WEAKNESS (Weakness in muscles and legs), BALANCE DISORDER (Fell twice after losing balance), FALL (a fall) and FATIGUE (Fatigue). On 26-May-2021, MUSCULAR WEAKNESS (Weakness in muscles and legs), BALANCE DISORDER (Fell twice after losing balance), FALL (a fall) and FATIGUE (Fatigue) had resolved.            Concomitant information was not reported. Treatment information was not reported. The action taken with mRNA-1273 with the event was considered as not applicable.   Reporter did not allow further contact
Slept almost 24 hrs; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Slept almost 24 hrs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was provided by the reporter.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced HYPERSOMNIA (Slept almost 24 hrs). At the time of the report, HYPERSOMNIA (Slept almost 24 hrs) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
coughing; face went numb as well as her tongue and hands for two and half days; face went numb as well as her tongue and hands for two and half days; maybe she had an allergic reaction to the first one; This is a spontaneous report from a contactable consumer (patient herself). This consumer reported similar events for two patients. This is one for two reports.  A 49-year-old female patient received BNT162B2 ((PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 04May2021 (Batch/Lot Number: EW0171) as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient reported that for the first 15 minutes she was fine but aafter like 25 minutes, her face went numb as well as her tongue and hands for two and half days. She was "feeling like death for two days and a half ." Because she needed to work that day, she took fexofenadine (ALLEGRA 180 mg) because "it's for allergies" and massaged her face, tongue and hands. After that, she felt okay. Her daughter, aged 18 had the same vaccine, and had the same exact reaction but received it at the+3  hospital. Her sister received Pfizer Covid 19 vaccine but in  its a 90 day interval between doses. Her doctor told her maybe she had an allergic reaction to the first one and wasn't sure if she should get the second dose. She was told to call Pfizer to see what they recommend. Primary care told her to call Pfizer to make sure if she is supposed to take the second one or if she needed to choose a different kind like Moderna or maybe Johnson and Johnson because of the side effect. Patient also stated "after my shot, I had horrible coughing. I am coughing for like 2 weeks but I don't know if it is related with my vaccine or not. I am going to hospital tonight to check." Outcome of the event coughing was unknown, and of remaining events was recovered on an unspecified date.  Additional information has been requested.
Itching, Hives to neck and back; Itching, Hives to neck and back; This is a spontaneous report from a contactable nurse (patient). A 44-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number=EK9231), via an unspecified route of administration on right arm at 08:45AM on 12Jan2021 at single dose for COVID-19 immunization. Medical history included hashimotos thyroid, mild exercise and allergy induced asthma, Allergies: Penicillin, Allergies: mold, Allergies: ragweed, Allergies: coconut, citrus. Concomitant medication included thyroid (ARMOUR THYROID), colecalciferol (VITAMIN D), vitamin c [ascorbic acid]. The patient previously received her first dose of bnt162b2 (Lot number=EK5730) at 09:00 AM on 22Dec2020 on right arm for COVID-19 immunization, PABA and experienced drug hypersensitivity. The patient experienced itching, hives to neck and back noted 25-30min after receiving vaccine at 09:15AM on 12Jan2021. Observed in vaccine clinic, vitals stable. Took Claritin 40min after vaccine. Hives resolving, no new symptoms at 90min post vaccine. Hives did return the next day when Claritin dose wore off; took another dose with Hives resolving within 2hours. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. The outcome of events was recovering.
Bell's Palsy; pharmacy was always out when I went for second dose; This case was reported by a consumer and described the occurrence of bell's palsy in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included chickenpox (experienced when the patient was child).   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, 183 days after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced bell's palsy (serious criteria GSK medically significant) and product supply issue. On an unknown date, the outcome of the bell's palsy and product supply issue were unknown.   The reporter considered the bell's palsy to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported. Six months to the vaccination date, the patient developed Bell's palsy.  The patient stated it seemed like, the patient should never have gotten Bell's palsy after receiving Shingrix. The patient stated that the pharmacy was always out when the patient went for the second dose.  It was reported that, 6 weeks in and the patient was referred to the university to the emergency medical technician (EMT) clinic for an evaluation for surgery. The patient would like to know how many other people had this side effect. The patient thought Bell's palsy was related to Shingrix vaccination.